Skip to main content

Table 3 Satisfaction with the BETACONNECT

From: Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study

Question

Initial visit

Follow-up visit after 4 weeks

Follow-up visit after 12 weeks

Follow-up visit after 24 weeks

…way of injection before study start

…BETACONNECT®

  
 

N = 93

N = 115

N = 109

N = 99

Satisfaction with…, NAS range 0–10

 Mean (SD)

7.4 (2.0)

8.3 (1.9)

8.5 (1.5)

8.4 (1.5)

 Median (range)

8 (1–10)

9 (1–10)

9 (2–10)

9 (3–10)

 

N = 94

N = 114

N = 110

N = 98

Injection related pain with…, NAS range 0–10

 Mean (SD)

4.2 (2.5)

3.6 (2.5)

4.0 (2.6)

4.1 (2.6)

 Median (range)

4 (0–10)

3 (0–10)

4 (0–10)

4 (0–10)

 

N = 96

N = 116

N = 111

N = 99

Prophylactic use of analgesics prior to injection with…, % (patients with corresponding questionnaire)

14.6

17.2

17.1

9.1

  1. NAS numerical analogue scale; SD standard deviation